Stability Study of a Compounded Sublingual Buprenorphine Solution for Neonatal Opioid Withdrawal Syndrome.

Ahmadi, Arash; Cutaia, Dina R; Perkins, Jarred R; Zhao, Fang; Gawronski, Kristen M; Austin, Daniel L

Ahmadi, Arash; Cutaia, Dina R; Perkins, Jarred R; Zhao, Fang; Gawronski, Kristen M; Austin, Daniel L.

Afiliação

Ahmadi A; School of Pharmacy (AA, DLA), Lake Erie College of Osteopathic Medicine, Erie, PA.
Cutaia DR; Wegmans School of Pharmacy (DRC, JRP, FZ), St. John Fisher University, Rochester, NY.
Perkins JR; Wegmans School of Pharmacy (DRC, JRP, FZ), St. John Fisher University, Rochester, NY.
Zhao F; Wegmans School of Pharmacy (DRC, JRP, FZ), St. John Fisher University, Rochester, NY.
Gawronski KM; Department of Pharmacy (KMG), University of Pittsburgh Medical Center Hamot, Erie, PA.
Austin DL; School of Pharmacy (AA, DLA), Lake Erie College of Osteopathic Medicine, Erie, PA.

J Pediatr Pharmacol Ther ; 28(8): 710-713, 2023.

Article em En | MEDLINE | ID: mdl-38094678

Palavras-chave

buprenorphine; drug compounding; drug stability; neonatal abstinence syndrome; pharmaceutical preservatives; sublingual administration; substance-related disorders

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Pediatr Pharmacol Ther Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Panamá País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google